000			01975 a2200625 4500
005			20250518084013.0
264		0	_c20210106
008			202101s 0 0 eng d
022			_a1556-1380
024	7		_a10.1016/j.jtho.2020.01.017 _2doi
040			_aNLM _beng _cNLM
100	1		_aGao, Shugeng
245	0	0	_aNeoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC. _h[electronic resource]
260			_bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _c05 2020
300			_a816-826 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmune Checkpoint Inhibitors
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aNeoadjuvant Therapy
700	1		_aLi, Ning
700	1		_aGao, Shunyu
700	1		_aXue, Qi
700	1		_aYing, Jianming
700	1		_aWang, Shuhang
700	1		_aTao, Xiuli
700	1		_aZhao, Jun
700	1		_aMao, Yousheng
700	1		_aWang, Bing
700	1		_aShao, Kang
700	1		_aLei, Wendong
700	1		_aWang, Dali
700	1		_aLv, Fang
700	1		_aZhao, Liang
700	1		_aZhang, Fan
700	1		_aZhao, Ziran
700	1		_aSu, Kai
700	1		_aTan, Fengwei
700	1		_aGao, Yibo
700	1		_aSun, Nan
700	1		_aWu, Dawei
700	1		_aYu, Yue
700	1		_aLing, Yun
700	1		_aWang, Zhijie
700	1		_aDuan, Chunjian
700	1		_aTang, Wei
700	1		_aZhang, Lei
700	1		_aHe, Shun
700	1		_aWu, Ning
700	1		_aWang, Jie
700	1		_aHe, Jie
773	0		_tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _gvol. 15 _gno. 5 _gp. 816-826
856	4	0	_uhttps://doi.org/10.1016/j.jtho.2020.01.017 _zAvailable from publisher's website
999			_c30612946 _d30612946